Simon Wagner
Oncology
Leicester Royal Infirmary
United Kingdom
Biography
Dr. Simon Wagner is currently working as a Professor in the Department of  Oncology , Leicester Royal Infirmary , United Kingdom. His research interests includes development and maintenance of B-cell malignancies. He is serving as an editorial member and reviewer of several international reputed journals. Dr. Simon Wagner is the member of many international affiliations. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to development and maintenance of B-cell malignancies.
Research Interest
Development and maintenance of B-cell malignancies, Microenvironment in driving survival and proliferation of chronic lymphocytic leukaemia.
Publications
-
Willimott, S., Beck, D., Ahearne, M. J., Adams, V. C., & Wagner, S. D. (2013). Cap-translation inhibitor, 4EGI-1 restores sensitivity to ABT-737 apoptosis through cap-dependent and independent mechanisms in chronic lymphocytic leukaemia.. Clin Cancer Res. doi:10.1158/1078-0432.CCR-12-2185
-
Dyer, M. J. S., Vogler, M., Wagner, S., Samuel, J., Pritchard, C., Macip, S., Jayne, S. (2013). Precision medicines for B-cell leukaemias and lymphomas; progress and potential pitfalls. British Journal of Haematology, 160(6), 725-733. doi:10.1111/bjh.12219
-
Ahearne, M. J., Willimott, S., Pinon, L., Kennedy, B., Miall, F., Dyer, M. J. S., Wagner, S. (2013). Increased numbers of circulating cells resembling T follicular helper (Tfh) cells in chronic lymphocytic leukaemia and enhancement of CD154/IL-4 proliferation by the Tfh cytokine, IL-21. BRITISH JOURNAL OF HAEMATOLOGY, 161, 46.
